Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lanthier

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
La Revue De Medecine Interne|February 11, 2020
[In patients with recent myocardial infarction, is colchicine effective in preventing cardiovascular events with a safety profile equivalent to placebo?]L Lanthier, C Dussault, G Huard, et al.
La Revue De Medecine Interne|April 22, 2020
[Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?]L Lanthier, N Bouchard, G Huard, et al.
La Revue De Medecine Interne|January 14, 2020
L Lanthier, C Dussault, G Huard, et al.
La Revue De Medecine Interne|November 10, 2020
[In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?]L Lanthier, C Dussault, G Huard, et al.
La Revue De Medecine Interne|June 6, 2020
[In ambulatory patients with suspected pulmonary embolism, does a new diagnostic strategy using D-dimers adjusted to clinical probability make it possible to safely exclude this diagnosis without using chest imaging?]L Lanthier, G Le Templier, G Huard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
An Analysis of Antibacterial Drug Development Trends in the United States, 1980-2019Nidhi Dheman, Nicole Mahoney, Edward M Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Accelerated approval and oncology drug development timelinesMichael L Lanthier, Rajeshwari Sridhara, John R Johnson, et al.
JAMA|January 23, 2014
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012Leonard V Sacks, Hala H Shamsuddin, Yuliya I Yasinskaya, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1984
Oxidation phenotyping in alcoholics with liver disease of varying severityP L Lanthier, R Reshef, R R Shah, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2009
Chronic antiplatelet therapy and mortality among patients with infective endocarditisJ Pepin, V Tremblay, D Bechard, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
La Revue De Medecine Interne|February 11, 2020
[In patients with recent myocardial infarction, is colchicine effective in preventing cardiovascular events with a safety profile equivalent to placebo?]L Lanthier, C Dussault, G Huard, et al.
La Revue De Medecine Interne|April 22, 2020
[Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?]L Lanthier, N Bouchard, G Huard, et al.
La Revue De Medecine Interne|January 14, 2020
L Lanthier, C Dussault, G Huard, et al.
La Revue De Medecine Interne|November 10, 2020
[In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?]L Lanthier, C Dussault, G Huard, et al.
La Revue De Medecine Interne|June 6, 2020
[In ambulatory patients with suspected pulmonary embolism, does a new diagnostic strategy using D-dimers adjusted to clinical probability make it possible to safely exclude this diagnosis without using chest imaging?]L Lanthier, G Le Templier, G Huard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
An Analysis of Antibacterial Drug Development Trends in the United States, 1980-2019Nidhi Dheman, Nicole Mahoney, Edward M Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Accelerated approval and oncology drug development timelinesMichael L Lanthier, Rajeshwari Sridhara, John R Johnson, et al.
JAMA|January 23, 2014
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012Leonard V Sacks, Hala H Shamsuddin, Yuliya I Yasinskaya, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1984
Oxidation phenotyping in alcoholics with liver disease of varying severityP L Lanthier, R Reshef, R R Shah, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2009
Chronic antiplatelet therapy and mortality among patients with infective endocarditisJ Pepin, V Tremblay, D Bechard, et al.
Pageof 5